These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7002102)

  • 41. The antihypertensive effects of quercetin in a salt-sensitive model of hypertension.
    Mackraj I; Govender T; Ramesar S
    J Cardiovasc Pharmacol; 2008 Mar; 51(3):239-45. PubMed ID: 18356687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK; Dubinion JH; Mi Z
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of captopril on blood pressure, urinary water and electrolyte excretion and drinking behaviour in Brattleboro rats.
    Gardiner SM; Bennett T
    Clin Sci (Lond); 1983 Dec; 65(6):589-97. PubMed ID: 6354558
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of angiotensin converting enzyme inhibitor on serum aldosterone and potassium level.
    Kamei H; Arakawa K
    Jpn Heart J; 1982 Mar; 23(2):191-9. PubMed ID: 7043022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Renin-angiotensin system and arterial hypertension. Mechanism of action of beta-blockers and captopril].
    Staroukine M; Giot JM; Jacobs W; Verniory A
    Bull Mem Acad R Med Belg; 1982; 137(12):723-36. PubMed ID: 6136306
    [No Abstract]   [Full Text] [Related]  

  • 46. [Comparison of the effects of betablockers and captopril on the development of genetic hypertension in the rat].
    Giudicelli JF; Richer C; Freslon JL; Glasson S; Decourt S
    Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():51-9. PubMed ID: 6117262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blood pressure regulation by angiotensin in the spontaneously hypertensive rats.
    Sokabe H; Kawashima K; Watanabe TX
    Adv Exp Med Biol; 1979; 120B():429-35. PubMed ID: 390989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute and chronic effects of captopril on the renin-angiotensin and kallikrein-kinin systems affecting blood pressure and natriuresis.
    Kida O
    Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):343-52. PubMed ID: 3894731
    [No Abstract]   [Full Text] [Related]  

  • 49. Efficacy of captopril in experimental low renin hypertension.
    Tikkanen I; Fyhrquist F; Tikkanen T; Miettinen A
    Eur J Pharmacol; 1980 Nov; 68(2):197-200. PubMed ID: 7009165
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of captopril on blood pressure, total body sodium and fluid consumption of genetically hypertensive (GH) and normotensive (N) rats.
    Ledingham JM; Simpson FO
    Clin Exp Hypertens (1978); 1981; 3(6):1239-63. PubMed ID: 7037339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Single-dose captopril administration in DOCA/salt rats: reduction of hypotensive effect by indomethacin.
    Miyamori I; Brown MJ; Dollery CT
    Clin Exp Hypertens (1978); 1980; 2(6):935-45. PubMed ID: 7004806
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic antihypertensive effects of captopril (SQ 14,225), an orally active angiotensin I-converting enzyme inhibitor, in conscious 2-kidney renal hypertensive rats.
    Rubin B; Antonaccio MJ; Goldberg ME; Harris DN; Itkin AG; Horovitz ZP; Panasevich RE; Laffan RJ
    Eur J Pharmacol; 1978 Oct; 51(4):377-88. PubMed ID: 213296
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of captopril on blood pressure in neurogenic hypertensive dogs.
    Montastruc P; Montastruc JL
    Arch Farmacol Toxicol; 1983 Apr; 9(1):47-52. PubMed ID: 6354107
    [No Abstract]   [Full Text] [Related]  

  • 54. Depressor effects of captopril in DOCA-salt hypertensive rats: role of vasopressin.
    Igarashi Y; Suzuki H; Itaya Y; Kondo K; Saruta T
    J Hypertens; 1985 Apr; 3(2):149-53. PubMed ID: 3894513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implication of endogenous prostaglandin system in the antihypertensive effect of captopril, SQ 14225, in low renin hypertension.
    Abe K; Itoh T; Imai Y; Sato M; Haruyama T; Sakurai Y; Goto T; Otsuka Y; Yoshinaga K
    Jpn Circ J; 1980 May; 44(5):422-5. PubMed ID: 6993721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dose dependency of captopril effects in severely hypertensive patients.
    Aldigier JC; Plouin PF; Alexandre JM; Corvol P; Menard J
    J Cardiovasc Pharmacol; 1981; 3(6):1229-35. PubMed ID: 6173522
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct renal action of captopril (SQ 14225): dissociation of natriuretic and vascular actions in isolated perfused rat kidney.
    Ogihara T; Yasui T; Nakane H; Nakane Y; Satura T
    Am J Cardiol; 1982 Apr; 49(6):1511-2. PubMed ID: 7041588
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Indomethacin and the hypotensive action of captopril in DOCA salt hypertensive rats [proceedings].
    Dollery CT; Miyamori I
    Br J Pharmacol; 1980 Jan; 68(1):117P-118P. PubMed ID: 6986936
    [No Abstract]   [Full Text] [Related]  

  • 59. Central renin-angiotensin system and the pathogenesis of DOCA-salt hypertension in rats.
    Itaya Y; Suzuki H; Matsukawa S; Kondo K; Saruta T
    Am J Physiol; 1986 Aug; 251(2 Pt 2):H261-8. PubMed ID: 3526927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Preventive effect of captopril on the development of genetic hypertension in SHR rats (author's transl)].
    Giudicelli JF; Freslon JL; Richer C
    Nouv Presse Med; 1981 Apr; 10(19):1547-9. PubMed ID: 6269556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.